XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.1
RESTRUCTURING AND OTHER EXIT COSTS (Notes)
3 Months Ended
Mar. 31, 2021
Restructuring and Related Activities [Abstract]  
RESTRUCTURING AND OTHER EXIT COSTS RESTRUCTURING AND OTHER EXIT COSTS In response to the reduction in the Company's business volumes as a result of the impact of the COVID-19 pandemic (see Note 1), during the year ended December 31, 2020, the Company took actions at all its brands to reduce the size of its workforce across more than 60 countries to optimize efficiency and reduce costs. As part of these actions, the Company engaged in consultations, with its employees, works councils, employee representatives and other relevant organizations related to the reductions in force in certain countries (including the Netherlands and the United Kingdom), which have substantially concluded as of December 31, 2020. These consultations resulted in the Company executing either voluntary leaver schemes or involuntary reductions in force, or, in some countries, a combination of the two. The Company completed the vast majority of
announcements to affected employees by December 2020. During the three months ended March 31, 2021, the Company approved and communicated the final portion of workforce reductions in the Netherlands, France and several other countries.

During the three months ended March 31, 2021, the Company recorded expenses of $8 million, for the restructuring actions, which are included in “Restructuring and other exit costs” in the Unaudited Consolidated Statement of Operations. These expenses are primarily cash-based and consist of employee severance and other termination benefits, and other costs. During the three months ended March 31, 2021, the Company made payments of $30 million. Noncash restructuring expenses and other adjustments to the restructuring liability during the three months ended March 31, 2021 were $3 million. At March 31, 2021 and December 31, 2020, restructuring liabilities of $12 million and $37 million, respectively, are included in "Accrued expenses and other current liabilities" in the Consolidated Balance Sheet.

As of March 31, 2021, the Company estimates that it will record additional restructuring expenses of approximately $20 million, related to employee severance and other termination benefits, leases and contract terminations, in the remainder of 2021. This estimate may change as the Company finalizes the execution of its cost reduction plans. The Company’s evaluation of various alternative courses of action related to certain other leases and contract terminations and modifications is still in progress and the Company may incur additional costs resulting from such actions.